- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AZN
Recent news which mentions AZN
From Motley Fool
AstraZeneca's Fasenra Flunks Late-Stage Trial In Patients With Esophagus Inflammation
October 25, 2022
From Benzinga
US Stock Futures Down; Big Tech Earnings In Focus
October 25, 2022
From Benzinga
AstraZeneca's Imfinzi Combo Scores FDA Approval For Liver Cancer
October 24, 2022
From Benzinga
US Stock Futures Lower Following Friday's Rally; Tesla In Focus
October 24, 2022
From Benzinga
Children's Hospitals Strained After Climbing Cases In Respiratory Illnesses In Kids
October 21, 2022
From Benzinga
3 Alzheimer's Therapy Stocks to Invest in
October 21, 2022
From Motley Fool
From Benzinga
Beat the Dow Jones With This Unstoppable Dividend Stock
October 19, 2022
From Motley Fool
7 Stocks to Buy When There’s Blood in the Streets
October 18, 2022
From InvestorPlace
2 Top Healthcare Stocks to Buy for the Long Haul
October 18, 2022
From Motley Fool
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
October 18, 2022
From InvestorPlace
This Growth Stock Rose Last Week. Is It Still a Buy?
October 18, 2022
From Motley Fool
2 Top Biotech Stocks to Buy Right Now
October 14, 2022
From Motley Fool
3 Incredibly Cheap Blue Chip Stocks to Buy Right Now
October 13, 2022
From Motley Fool
2 No-Brainer Stocks to Buy Right Now for Less Than $100
October 12, 2022
From Motley Fool
Is Seagen Stock a Buy Now?
October 12, 2022
From Motley Fool
From Benzinga
Twitter May Drop Clickable Hashtags, AstraZeneca's Nasal COVID-19 Vaccine Fails Trial, Coinbase Gets Singapore Nod: Top Stories Tuesday, Oct. 11
October 11, 2022
From Benzinga
From Benzinga
Have $2,000? 2 Market Crash-Ready Stocks to Buy
October 09, 2022
From Motley Fool
2 Healthcare Stocks That Could Help Make You a Fortune
October 08, 2022
From Motley Fool
From MarketWatch
War over drug-cost assistance traps sickest patients in the middle
October 03, 2022
From MarketWatch
Will Chart Analysts Notice Bad Omen on AstraZeneca's Chart
October 03, 2022
Tickers
AZN
From Benzinga
Why Is LogicBio (LOGC) Stock Up 600% Today?
October 03, 2022
From InvestorPlace
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
October 03, 2022
From Benzinga
Why LogicBio Therapeutics Stock Is Soaring Today
October 03, 2022
From Benzinga
Why Are LogicBio Therapeutics Shares Skyrocketing Today?
October 03, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.